The c-Jun N-terminal kinase (JNK), which is well-established for its essential role in anti-cancer agent-elicited apoptosis, was also activated by triptonide as indicated by immunoblotting of increased phosphorylated JNK (p-JNK) (Fig. 1c). The gene discussed is MAPK8; the disease is cancer.